2017 annual report
letter to our shareholders
company highlights
consolidated statement of operations
driving commercial adoption
expanding reimbursement
Nikki Woolfolk, Optune user
Matt Lozano, Senior Device Support Specialist
advancing our clinical pipeline
we can leverage physics to fight cancer
Ori Farber, Senior Medical Manager
Professor Ignace Vergote, clinical trial investigator
building long-term shareholder value
positioned for future growth
significant unmet medical need
Tomoe Kamata, Special Project Manager
Pritesh Shah, Senior Vice President of the Americas
Novocure leadership
downloads
building a global oncology platform
explore our world
Novocure U.S.
Novocure Jersey
Novocure Switzerland
Novocure Germany
Novocure Israel
Novocure Japan
Novocure Canada
explore
our world
letter to our shareholders
driving commercial adoption
advancing our clinical pipeline
building long-term shareholder value